Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01-15

AUTHORS

Douglas Mapel, Michael Schum, Marianne Yood, Jeffrey Brown, David Miller, Kourtney Davis

ABSTRACT

AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96–1.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69–1.22) or SFC (OR=1.03; 95%CI: 0.74–1.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia. More... »

PAGES

109-117

Identifiers

URI

http://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072

DOI

http://dx.doi.org/10.4104/pcrj.2009.00072

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041801277

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20082059


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Inhalation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenal Cortex Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androstadienes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchodilator Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delayed-Action Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluticasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Longitudinal Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pneumonia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Disease, Chronic Obstructive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salmeterol Xinafoate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA", 
          "id": "http://www.grid.ac/institutes/grid.419338.4", 
          "name": [
            "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mapel", 
        "givenName": "Douglas", 
        "id": "sg:person.01204002445.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204002445.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA", 
          "id": "http://www.grid.ac/institutes/grid.419338.4", 
          "name": [
            "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schum", 
        "givenName": "Michael", 
        "id": "sg:person.0632005344.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005344.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yood", 
        "givenName": "Marianne", 
        "id": "sg:person.0754044324.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754044324.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Jeffrey", 
        "id": "sg:person.016162107014.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016162107014.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline, Research Triangle Park, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline, Research Triangle Park, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miller", 
        "givenName": "David", 
        "id": "sg:person.01133555375.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133555375.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline, Research Triangle Park, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline, Research Triangle Park, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "Kourtney", 
        "id": "sg:person.0724211141.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724211141.21"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-01-15", 
    "datePublishedReg": "2010-01-15", 
    "description": "AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96\u20131.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69\u20131.22) or SFC (OR=1.03; 95%CI: 0.74\u20131.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia.", 
    "genre": "article", 
    "id": "sg:pub.10.4104/pcrj.2009.00072", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1371256", 
        "issn": [
          "1471-4418", 
          "2055-1010"
        ], 
        "name": "npj Primary Care Respiratory Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "risk of pneumonia", 
      "combination inhaler", 
      "COPD patients", 
      "odds ratio", 
      "non-significant increased risk", 
      "cases of pneumonia", 
      "adjusted odds ratio", 
      "MethodThe study population", 
      "case-control method", 
      "increased risk", 
      "lung disease", 
      "clinical history", 
      "advanced age", 
      "study population", 
      "pneumonia", 
      "only treatment", 
      "patients", 
      "corticosteroids", 
      "bronchodilators", 
      "care organizations", 
      "risk", 
      "inhaler", 
      "administrative data", 
      "SABD", 
      "treatment", 
      "COPD", 
      "ConclusionTreatment", 
      "AimTo", 
      "therapy", 
      "LABA", 
      "disease", 
      "severity", 
      "age", 
      "population", 
      "individuals", 
      "database", 
      "history", 
      "cases", 
      "different parts", 
      "IC", 
      "combination", 
      "data", 
      "ratio", 
      "USA", 
      "part", 
      "method", 
      "organization", 
      "users"
    ], 
    "name": "Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators", 
    "pagination": "109-117", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041801277"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.4104/pcrj.2009.00072"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20082059"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.4104/pcrj.2009.00072", 
      "https://app.dimensions.ai/details/publication/pub.1041801277"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.4104/pcrj.2009.00072"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      20 PREDICATES      96 URIs      88 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.4104/pcrj.2009.00072 schema:about N327b4269a5844443a42c3fa8e22e7c3d
2 N42227d439b844df3be2be6b8aff4acb3
3 N4bc7b358399c45c58621e2561859be25
4 N572ce5f834214dec8533f9237331e8a4
5 N575106f77cbb43969d7739b2a73bb1da
6 N7539e2206d1347428ee09c751bee60e9
7 N77c7eb32d7b646a0b16c59c57bbb2045
8 N7ea6ee0cbcca4a68971cc755220c50d9
9 N87d06fd5125b43598bce4541d42a574d
10 N8f01e8bd4d1949f38f5f59d5462a1fd9
11 N9cbe466217564da08070424bbd9103fc
12 Na0fe82620d8843f59d51f8d90d4a2aa1
13 Na4d9d61f7dc14901a22bec55979bef16
14 Na9b37b96be0649d69efe27267a34d270
15 Nab2de743164a41ae8208c5d3d87a6050
16 Naeba351befaa4abf9b00de8fc5c2e6dd
17 Nb5cbbcdc1aea4b258c5b012f03d87426
18 Nbfd11e28734a46e3a42c7fa6273e5f35
19 Nd1dd93c119b54bd2ad1fa6db5a2bcc42
20 Nd565c1ccee9c4649a4e496a7227e8559
21 Nd622b5efe50b40ae90dd63b39ac45e50
22 Nf130095a95044cd7b59cac7746e6d7b6
23 Nff22090e38694122947da00d51a38e46
24 anzsrc-for:11
25 anzsrc-for:1102
26 schema:author N82bc508ed83c40549fe19ee3221e1436
27 schema:datePublished 2010-01-15
28 schema:datePublishedReg 2010-01-15
29 schema:description AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96–1.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69–1.22) or SFC (OR=1.03; 95%CI: 0.74–1.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N2b7bf3f3494a43ad97d536298601bd5d
33 N98c376967b64473ca770ca82a4665cdc
34 sg:journal.1371256
35 schema:keywords AimTo
36 COPD
37 COPD patients
38 ConclusionTreatment
39 IC
40 LABA
41 MethodThe study population
42 SABD
43 USA
44 adjusted odds ratio
45 administrative data
46 advanced age
47 age
48 bronchodilators
49 care organizations
50 case-control method
51 cases
52 cases of pneumonia
53 clinical history
54 combination
55 combination inhaler
56 corticosteroids
57 data
58 database
59 different parts
60 disease
61 history
62 increased risk
63 individuals
64 inhaler
65 lung disease
66 method
67 non-significant increased risk
68 odds ratio
69 only treatment
70 organization
71 part
72 patients
73 pneumonia
74 population
75 ratio
76 risk
77 risk of pneumonia
78 severity
79 study population
80 therapy
81 treatment
82 users
83 schema:name Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators
84 schema:pagination 109-117
85 schema:productId Nbffb3895ecce4d0595b890e3df19d611
86 Nf58e16d782294166879a7efb78519a9f
87 Nfc90d1cbf9924a829eafef43c3c7b50b
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041801277
89 https://doi.org/10.4104/pcrj.2009.00072
90 schema:sdDatePublished 2022-08-04T16:58
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N0af271e6cd3b424da689159ddd26550d
93 schema:url https://doi.org/10.4104/pcrj.2009.00072
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N0af271e6cd3b424da689159ddd26550d schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N2b7bf3f3494a43ad97d536298601bd5d schema:issueNumber 2
100 rdf:type schema:PublicationIssue
101 N327b4269a5844443a42c3fa8e22e7c3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Male
103 rdf:type schema:DefinedTerm
104 N38bcfed134f6464f99dfefc18172f27f rdf:first sg:person.016162107014.93
105 rdf:rest Neb30d04b2ba24238b4702c0a39b5f343
106 N42227d439b844df3be2be6b8aff4acb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Fluticasone
108 rdf:type schema:DefinedTerm
109 N4ad00dfbca524bdb9ef909e0412f6cd0 rdf:first sg:person.0632005344.67
110 rdf:rest N742503710bc547c9aced471a028c37b1
111 N4bc7b358399c45c58621e2561859be25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Severity of Illness Index
113 rdf:type schema:DefinedTerm
114 N572ce5f834214dec8533f9237331e8a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Case-Control Studies
116 rdf:type schema:DefinedTerm
117 N575106f77cbb43969d7739b2a73bb1da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Drug Therapy, Combination
119 rdf:type schema:DefinedTerm
120 N742503710bc547c9aced471a028c37b1 rdf:first sg:person.0754044324.05
121 rdf:rest N38bcfed134f6464f99dfefc18172f27f
122 N7539e2206d1347428ee09c751bee60e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Odds Ratio
124 rdf:type schema:DefinedTerm
125 N77c7eb32d7b646a0b16c59c57bbb2045 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Adult
127 rdf:type schema:DefinedTerm
128 N7ea6ee0cbcca4a68971cc755220c50d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Adrenal Cortex Hormones
130 rdf:type schema:DefinedTerm
131 N82bc508ed83c40549fe19ee3221e1436 rdf:first sg:person.01204002445.88
132 rdf:rest N4ad00dfbca524bdb9ef909e0412f6cd0
133 N87d06fd5125b43598bce4541d42a574d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Age Factors
135 rdf:type schema:DefinedTerm
136 N8f01e8bd4d1949f38f5f59d5462a1fd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Administration, Inhalation
138 rdf:type schema:DefinedTerm
139 N91054bef93a449f193a897cef7ab6533 rdf:first sg:person.0724211141.21
140 rdf:rest rdf:nil
141 N98c376967b64473ca770ca82a4665cdc schema:volumeNumber 19
142 rdf:type schema:PublicationVolume
143 N9cbe466217564da08070424bbd9103fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Aged
145 rdf:type schema:DefinedTerm
146 Na0fe82620d8843f59d51f8d90d4a2aa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Albuterol
148 rdf:type schema:DefinedTerm
149 Na4d9d61f7dc14901a22bec55979bef16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Middle Aged
151 rdf:type schema:DefinedTerm
152 Na9b37b96be0649d69efe27267a34d270 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Androstadienes
154 rdf:type schema:DefinedTerm
155 Nab2de743164a41ae8208c5d3d87a6050 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Salmeterol Xinafoate
157 rdf:type schema:DefinedTerm
158 Naeba351befaa4abf9b00de8fc5c2e6dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Humans
160 rdf:type schema:DefinedTerm
161 Nb5cbbcdc1aea4b258c5b012f03d87426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Risk Factors
163 rdf:type schema:DefinedTerm
164 Nbfd11e28734a46e3a42c7fa6273e5f35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Female
166 rdf:type schema:DefinedTerm
167 Nbffb3895ecce4d0595b890e3df19d611 schema:name dimensions_id
168 schema:value pub.1041801277
169 rdf:type schema:PropertyValue
170 Nd1dd93c119b54bd2ad1fa6db5a2bcc42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Longitudinal Studies
172 rdf:type schema:DefinedTerm
173 Nd565c1ccee9c4649a4e496a7227e8559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Pulmonary Disease, Chronic Obstructive
175 rdf:type schema:DefinedTerm
176 Nd622b5efe50b40ae90dd63b39ac45e50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Delayed-Action Preparations
178 rdf:type schema:DefinedTerm
179 Neb30d04b2ba24238b4702c0a39b5f343 rdf:first sg:person.01133555375.45
180 rdf:rest N91054bef93a449f193a897cef7ab6533
181 Nf130095a95044cd7b59cac7746e6d7b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Bronchodilator Agents
183 rdf:type schema:DefinedTerm
184 Nf58e16d782294166879a7efb78519a9f schema:name pubmed_id
185 schema:value 20082059
186 rdf:type schema:PropertyValue
187 Nfc90d1cbf9924a829eafef43c3c7b50b schema:name doi
188 schema:value 10.4104/pcrj.2009.00072
189 rdf:type schema:PropertyValue
190 Nff22090e38694122947da00d51a38e46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Pneumonia
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
197 schema:name Cardiorespiratory Medicine and Haematology
198 rdf:type schema:DefinedTerm
199 sg:journal.1371256 schema:issn 1471-4418
200 2055-1010
201 schema:name npj Primary Care Respiratory Medicine
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01133555375.45 schema:affiliation grid-institutes:grid.418019.5
205 schema:familyName Miller
206 schema:givenName David
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133555375.45
208 rdf:type schema:Person
209 sg:person.01204002445.88 schema:affiliation grid-institutes:grid.419338.4
210 schema:familyName Mapel
211 schema:givenName Douglas
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204002445.88
213 rdf:type schema:Person
214 sg:person.016162107014.93 schema:affiliation grid-institutes:grid.38142.3c
215 schema:familyName Brown
216 schema:givenName Jeffrey
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016162107014.93
218 rdf:type schema:Person
219 sg:person.0632005344.67 schema:affiliation grid-institutes:grid.419338.4
220 schema:familyName Schum
221 schema:givenName Michael
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005344.67
223 rdf:type schema:Person
224 sg:person.0724211141.21 schema:affiliation grid-institutes:grid.418019.5
225 schema:familyName Davis
226 schema:givenName Kourtney
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724211141.21
228 rdf:type schema:Person
229 sg:person.0754044324.05 schema:affiliation grid-institutes:grid.47100.32
230 schema:familyName Yood
231 schema:givenName Marianne
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754044324.05
233 rdf:type schema:Person
234 grid-institutes:grid.38142.3c schema:alternateName Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA
235 schema:name Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA
236 rdf:type schema:Organization
237 grid-institutes:grid.418019.5 schema:alternateName GlaxoSmithKline, Research Triangle Park, North Carolina, USA
238 schema:name GlaxoSmithKline, Research Triangle Park, North Carolina, USA
239 rdf:type schema:Organization
240 grid-institutes:grid.419338.4 schema:alternateName Lovelace Clinic Foundation, Albuquerque, New Mexico, USA
241 schema:name Lovelace Clinic Foundation, Albuquerque, New Mexico, USA
242 rdf:type schema:Organization
243 grid-institutes:grid.47100.32 schema:alternateName Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA
244 schema:name Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...